Semper Paratus Acquisition Corp. (LGST) Shareholders Approve Tevogen Bio Deal
by Marlena Haddad on 2024-02-01 at 8:58am

Semper Paratus (Nasdaq: LGST) announced this morning that its shareholders approved its combination with Tevogen Bio during a special meeting yesterday January 31.

In connection with the vote, shareholders holding 1,432,457 shares out of a possible 1,502,180 Semper Paratus ordinary shares opted to redeem their shares. While the final amount of the funds to be removed from the trust is still being calculated, the current preliminary calculations are that approximately $15.9 million, or $11.07 per share, will be removed from the trust.

Including prior votes, LGST shareholders have redeemed an aggregate of 99.8% of the SPAC’s trust thus far, leaving it with roughly $800,000 and 69,723 shares remaining.

The parties did not provide a timeline for the closing of the deal, but it is expected to be completed as soon as practicable following the satisfaction of the remaining closing conditions, including approval for listing on The Nasdaq.

Following the closing of the deal, the common stock of the combined company is expected to begin trading on Nasdaq under the symbol “TVGN”.

Semper Paratus inked its $1.2 billion deal with Tevogen Bio in June 2023. Warren, New Jersey-based Tevogen is developing a treatment to boost the immune systems of COVID patients undergoing cancer treatments or that have other comorbidities.

All other proposals presented on the ballot were also approved at the meeting .

Recent Posts
by Nicholas Alan Clayton on 2024-11-19 at 8:20am

At the SPAC of Dawn Although the drought of new SPAC transactions is approaching one full month, that hasn’t stopped the dealmaking between de-SPACs themselves. Trump Media (NASDAQ:DJT) is reportedly in advanced talks to buy crypto and digital asset marketplace and 2021 de-SPAC Bakkt (NYSE:BKKT) in an all-stock deal, according to FT. The former target...

by Nicholas Alan Clayton on 2024-11-18 at 3:08pm

Columbus Acquisition Corp (NASDAQ:COLAU) has filed for a $57.5 million IPO to give its team a second vehicle in circulation to hunt for deals. The same team IPO’d Eureka (NASDAQ:EURK) in July at a slightly smaller $50 million scale and this new SPAC would improve upon some of that foray’s terms. Both SPACs managed to...

by Nicholas Alan Clayton on 2024-11-18 at 8:20am

At the SPAC of Dawn One week before Thanksgiving, SPACs are not filling up their plate with just five votes scheduled, all of which are extensions. Five of these are set to take place today, and investors are also set to get an update on one of the most successful de-SPACs of recent years. Industrial...

by Kristi Marvin on 2024-11-16 at 10:00am

Terms Tracker for the Week Ending November 15, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The drought in De-SPAC deals continues without a single announced combination since October 23rd. That’s more than three weeks now with SPACs experiencing a dry...

by Nicholas Alan Clayton on 2024-11-15 at 11:28am

Few corners of the market have seen a bigger boost from the result of the US elections than the crypto industry, and SPACs are always sure to be drawn to where the action is. But, in crypto’s case, this is a play that SPACs have been involved in before, so the question is more of...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved